The Claim

In older adults with ischemic systolic heart failure, daily administration of 10 mg rosuvastatin has no statistically significant effect on the composite endpoint of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke, as indicated by a hazard ratio of 0.92 (95% CI, 0.83–1.02; P=0.12).

Source: Rosuvastatin in older patients with systolic heart failure.

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
72score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Quantitative
1 study reviewed
In plain English

In older adults with a type of heart failure caused by blocked arteries, taking 10 mg of rosuvastatin daily does not reduce the combined risk of dying from heart problems, having a heart attack, or having a stroke.

See the scientific wording

In older adults with ischemic systolic heart failure, daily 10 mg rosuvastatin does not significantly reduce the composite endpoint of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke, with a hazard ratio of 0.92 (95% CI, 0.83–1.02; P=0.12), indicating no statistically significant effect on the primary clinical outcome despite theoretical benefits.

Why this might work

Rosuvastatin lowers cholesterol and reduces inflammation in the blood, which improves blood flow in small heart vessels and decreases hospital visits, but it does not stop heart attacks, strokes, or death in older people with severe heart failure because the underlying damage to the heart and arteries is too advanced for these changes to prevent major events.

Supported mechanismbased on 1 study

What the research says

1 study

  1. Study: Rosuvastatin in older patients with systolic heart failure.

    In older people with heart failure caused by blocked arteries, taking rosuvastatin daily for nearly three years didn’t lower their risk of dying from heart problems, having a heart attack, or having a stroke — even though it made their blood markers better and reduced hospital visits.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.